POINT Biopharma Stock Forecast - Polynomial Regression

PNTDelisted Stock  USD 12.50  0.00  0.00%   
The Polynomial Regression forecasted value of POINT Biopharma Global on the next trading day is expected to be 11.97 with a mean absolute deviation of  0.20  and the sum of the absolute errors of 12.39. POINT Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast POINT Biopharma stock prices and determine the direction of POINT Biopharma Global's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of POINT Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
  
Most investors in POINT Biopharma cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the POINT Biopharma's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets POINT Biopharma's price structures and extracts relationships that further increase the generated results' accuracy.
POINT Biopharma polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for POINT Biopharma Global as well as the accuracy indicators are determined from the period prices.

POINT Biopharma Polynomial Regression Price Forecast For the 24th of April

Given 90 days horizon, the Polynomial Regression forecasted value of POINT Biopharma Global on the next trading day is expected to be 11.97 with a mean absolute deviation of 0.20, mean absolute percentage error of 0.08, and the sum of the absolute errors of 12.39.
Please note that although there have been many attempts to predict POINT Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that POINT Biopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

POINT Biopharma Stock Forecast Pattern

Backtest POINT BiopharmaPOINT Biopharma Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of POINT Biopharma stock data series using in forecasting. Note that when a statistical model is used to represent POINT Biopharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria115.5503
BiasArithmetic mean of the errors None
MADMean absolute deviation0.2031
MAPEMean absolute percentage error0.0155
SAESum of the absolute errors12.3884
A single variable polynomial regression model attempts to put a curve through the POINT Biopharma historical price points. Mathematically, assuming the independent variable is X and the dependent variable is Y, this line can be indicated as: Y = a0 + a1*X + a2*X2 + a3*X3 + ... + am*Xm

Predictive Modules for POINT Biopharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as POINT Biopharma Global. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of POINT Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
12.5012.5012.50
Details
Intrinsic
Valuation
LowRealHigh
10.9610.9613.75
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as POINT Biopharma. Your research has to be compared to or analyzed against POINT Biopharma's peers to derive any actionable benefits. When done correctly, POINT Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in POINT Biopharma Global.

View POINT Biopharma Related Equities

 Risk & Return  Correlation

POINT Biopharma Market Strength Events

Market strength indicators help investors to evaluate how POINT Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading POINT Biopharma shares will generate the highest return on investment. By undertsting and applying POINT Biopharma stock market strength indicators, traders can identify POINT Biopharma Global entry and exit signals to maximize returns.

POINT Biopharma Risk Indicators

The analysis of POINT Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in POINT Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting point stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as POINT Biopharma Global using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in POINT Stock

If you are still planning to invest in POINT Biopharma Global check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the POINT Biopharma's history and understand the potential risks before investing.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Valuation
Check real value of public entities based on technical and fundamental data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
CEOs Directory
Screen CEOs from public companies around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities